治療COVID-19的藥物簡介

Introduction to drugs for the treatment of COVID-19

COVID-19的疫情從2020開始影響了全世界，迅速的傳播與一開始超乎預期的死亡率，讓大家關住在發展有效的治療上，陸續有許多傳統的藥物或是新用法在臨床上被使用著，以期能達到控制病情降低死亡率甚至消滅病毒的目標，包括奎寧與抗愛滋病毒藥物，雖然一開始被認為可以用來治療COVID-19，但後續大規模的研究證明上述藥物並沒有療效，目前被國內指引認可的藥物僅有抗病毒藥物瑞德西偉和抗發炎藥物類固醇，臨床可以針對符合適應症COVID-19病人，給予適當的處置。

The COVID-19 pandemic has been ongoing since 2020. The rapid spread and the unexpected mortality rate at the beginning of the ensuing pandemic focused attention on the development of effective treatments. Many traditional medications may be useful for the treatment of COVID-19. The aims of these therapies were to control disease, reduce mortality, and even eliminate the virus. Quinine and drugs active against human immunodeficiency virus were initially administered by some clinicians. However, there were no data from large-scale studies to support their use. At present, the two only drugs approved by the Taiwan Center for Disease Control are the antiviral drug remdesivir and anti-inflammatory steroids, which can be prescribed to clinical patients.